To determine if the IL-15 complex delivered intratumorally could improve anti-PD-1 therapy, C57BL/6 mice were first inoculated with the luminal B breast cancer cell line EO771 in the mammary fat pad. The gene discussed is IL15; the disease is breast carcinoma.